Scopus BioPharma Late Friday Reported Its Annual Shareholder Meeting Was Adjourned Til Friday, Nov. 5, 2021 At 1 p.m. ET
Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, today announced that, on